SCHEMBL31740951

SCHEMBL31740951

CC(C)(C)OC(=O)N1CCN(CC(F)(F)F)[C@H](C(=O)O)C1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 1/20 0.40
MAPT P10636 2/20 0.39
MEN1 O00255 1/20 0.39
ALDH1A1 P00352 1/20 0.39
KMT2A Q03164 1/20 0.39
RORC P51449 1/20 0.39
MCL1 Q07820 1/20 0.38
USP2 O75604 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
GPR119 Q8TDV5 1/20 0.38
JAK2 O60674 1/20 0.38
JAK1 P23458 1/20 0.38
MMP1 P03956 1/20 0.37
MMP3 P08254 1/20 0.37
MMP7 P09237 1/20 0.37
MMP9 P14780 1/20 0.37
HSD17B10 Q99714 1/20 0.37
LIPE Q05469 1/20 0.37
KDM4E B2RXH2 1/20 0.37
PKM P14618 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30859827 1.00 NR1H2 (0.40) NR1H2MAPTMEN1ALDH1A1KMT2A
SCHEMBL31741194 0.87 MMP1 (0.40) NR1H2MAPTMEN1ALDH1A1KMT2A
SCHEMBL30860045 0.87 MMP1 (0.40) NR1H2MAPTMEN1ALDH1A1KMT2A
SCHEMBL31740434 0.84 DPP4 (0.40) NR1H2MAPTMEN1ALDH1A1KMT2A
SCHEMBL28721432 0.83 NR1H2 (0.41) NR1H2MAPTMEN1ALDH1A1KMT2A
SCHEMBL28722417 0.83 NR1H2 (0.41) NR1H2MAPTMEN1ALDH1A1KMT2A
SCHEMBL28721431 0.83 NR1H2 (0.41) NR1H2MAPTMEN1ALDH1A1KMT2A
SCHEMBL12524859 0.81 NR1H2 (0.46) NR1H2MAPTMEN1ALDH1A1KMT2A
SCHEMBL28719822 0.81 NR1H2 (0.40) NR1H2MAPTMEN1ALDH1A1KMT2A
SCHEMBL17079757 0.81 ALDH1A1 (0.43) NR1H2MAPTMEN1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250368625-A1 PIPERAZINES Grünenthal GmbH (DE) 2025-12-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250368625-A1 PIPERAZINES SSTR4, SSTR5, SSTR2 NR1H2 478/4885MAPT 3682/4885MEN1 4044/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.